Home » Topics » BioWorld Science, Immune

BioWorld Science, Immune
RSS

Thalidomide analogue CC-3052 is more active, less toxic than parent drug

Nov. 23, 1998

Phase II data demonstrate efficacy of Avant's rotavirus vaccine

Nov. 23, 1998

SangCya launched in U.S. less than three weeks following approval

Nov. 20, 1998

Intellivax presents promising phase I data for intranasal vaccine for shigellosis

Nov. 20, 1998

New LYMErix study results point to faster immunization

Nov. 19, 1998

Axis Genetics enters collaboration for edible plant vaccine development

Nov. 18, 1998

BTG to commercialize new approach to bacterial vaccines

Nov. 16, 1998

Mizoribine evaluated in children with frequently relapsing nephrotic syndrome

Nov. 13, 1998

New mechanism of action described for immunomodulating agent OM-89

Nov. 12, 1998

Rotavirus vaccine now on the market in U.S.

Nov. 6, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...